Janney Montgomery Scott LLC Abb Vie Inc. Transaction History

Janney Montgomery Scott LLC

$35.8 Billion
Q3 2024

A detailed history of Janney Montgomery Scott LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Janney Montgomery Scott LLC holds 931,310 shares of ABBV stock, worth $156 Million. This represents 0.51% of its overall portfolio holdings.

Number of Shares

931,310

Previous 946,705 1.63%

Holding current value

$156 Million

Previous $162 Million 13.26%

% of portfolio

0.51%

Previous 0.5%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	SELL	$163.84 - $199.33 $2.52 Million - $3.07 Million	-15,395 Reduced 1.63%	931,310 $184 Million
Q2 2024 Jul 25, 2024	SELL	$154.79 - $180.76 $6.51 Million - $7.6 Million	-42,045 Reduced 4.25%	946,705 $162 Million
Q1 2024 May 01, 2024	BUY	$159.82 - $182.1 $2.87 Million - $3.27 Million	17,957 Added 1.85%	988,750 $180 Million
Q4 2023 Feb 07, 2024	BUY	$137.6 - $154.97 $5.81 Million - $6.55 Million	42,242 Added 4.55%	970,793 $150 Million
Q3 2023 Nov 08, 2023	BUY	$133.59 - $154.65 $79,352 - $91,862	594 Added 0.06%	928,551 $138 Million
Q2 2023 Jul 26, 2023	SELL	$132.51 - $164.9 $3.4 Million - $4.24 Million	-25,696 Reduced 2.69%	927,957 $125 Million
Q1 2023 Apr 28, 2023	SELL	$144.61 - $166.54 $9.5 Million - $10.9 Million	-65,672 Reduced 6.44%	953,653 $152 Million
Q4 2022 Feb 01, 2023	BUY	$138.31 - $165.87 $6.6 Million - $7.92 Million	47,753 Added 4.92%	1,019,325 $165 Million
Q3 2022 Oct 25, 2022	BUY	$134.21 - $153.93 $5.25 Million - $6.02 Million	39,093 Added 4.19%	971,572 $130 Million
Q2 2022 Aug 03, 2022	BUY	$137.62 - $174.96 $4.61 Million - $5.86 Million	33,505 Added 3.73%	932,479 $142 Million
Q1 2022 May 04, 2022	BUY	$131.98 - $163.75 $525,016 - $651,397	3,978 Added 0.44%	898,974 $146 Million
Q4 2021 Jan 27, 2022	BUY	$107.43 - $135.93 $4 Million - $5.06 Million	37,253 Added 4.34%	894,996 $121 Million
Q3 2021 Oct 29, 2021	BUY	$106.4 - $120.78 $4.38 Million - $4.98 Million	41,195 Added 5.05%	857,743 $92.5 Million
Q2 2021 Jul 26, 2021	BUY	$105.21 - $117.21 $1.1 Million - $1.22 Million	10,430 Added 1.29%	816,548 $92 Million
Q1 2021 Apr 27, 2021	BUY	$102.3 - $112.62 $9.55 Million - $10.5 Million	93,340 Added 13.1%	806,118 $87.2 Million
Q4 2020 Jan 25, 2021	BUY	$80.49 - $108.67 $1.37 Million - $1.85 Million	17,049 Added 2.45%	712,778 $76.4 Million
Q3 2020 Nov 06, 2020	BUY	$85.91 - $100.83 $3.46 Million - $4.06 Million	40,222 Added 6.14%	695,729 $60.9 Million
Q2 2020 Jul 23, 2020	BUY	$73.37 - $98.18 $2.81 Million - $3.76 Million	38,318 Added 6.21%	655,507 $64.4 Million
Q1 2020 Apr 30, 2020	BUY	$64.5 - $97.79 $1.83 Million - $2.78 Million	28,433 Added 4.83%	617,189 $47 Million
Q4 2019 Jan 21, 2020	BUY	$72.13 - $90.25 $1.72 Million - $2.15 Million	23,796 Added 4.21%	588,756 $52.1 Million
Q3 2019 Oct 29, 2019	BUY	$62.98 - $75.72 $2.42 Million - $2.91 Million	38,390 Added 7.29%	564,960 $42.8 Million
Q2 2019 Jul 29, 2019	BUY	$65.7 - $83.98 $3.61 Million - $4.62 Million	55,014 Added 11.67%	526,570 $38.3 Million
Q1 2019 Apr 30, 2019	BUY	$77.14 - $90.79 $101,130 - $119,025	1,311 Added 0.28%	471,556 $38 Million
Q4 2018 Feb 01, 2019	SELL	$77.85 - $96.01 $2.71 Million - $3.34 Million	-34,755 Reduced 6.88%	470,245 $43.4 Million
Q3 2018 Nov 05, 2018	SELL	$88.91 - $98.84 $327,811 - $364,423	-3,687 Reduced 0.72%	505,000 $47.8 Million
Q2 2018 Jul 24, 2018	BUY	$89.78 - $106.23 $289,989 - $343,122	3,230 Added 0.64%	508,687 $47.1 Million
Q1 2018 Apr 19, 2018	SELL	$92.01 - $123.21 $2.83 Million - $3.79 Million	-30,748 Reduced 5.73%	505,457 $47.8 Million
Q4 2017 Feb 14, 2018	SELL	$89.56 - $98.21 $1.53 Million - $1.68 Million	-17,069 Reduced 3.09%	536,205 $51.9 Million
Q3 2017 Nov 15, 2017	BUY	$69.85 - $89.22 $38.6 Million - $49.4 Million	553,274	553,274 $49.2 Million

Others Institutions Holding ABBV

# of Institutions

3,846

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $297B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Janney Montgomery Scott LLC, based on Form 13F filings with the SEC.

News

Stay updated on Janney Montgomery Scott LLC with notifications on news.

Account

Janney Montgomery Scott LLC Abb Vie Inc. Transaction History